DUBLIN, Nov. 16, 2020 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that the primary results of the Medtronic-sponsored STOP AF First clinical ...
Medtronic plc MDT announced the receipt of an expanded approval from the FDA for its Arctic Front Family of Cardiac Cryoablation Catheters to treat recurrent symptomatic paroxysmal atrial fibrillation ...
ESC Congress: New Research Highlights First-Line Use of Cryoablation as Highly Effective, and with Improved Quality of Life Scores DUBLIN, Aug. 29, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), ...
Summer may just be getting started, but Medtronic has colder temperatures on the brain. Much colder temperatures, in fact, with the FDA’s expanded clearance of the company’s cryoablation catheter to ...
- First and Only Approval to Indicate Cryoablation as an Initial Rhythm Control Strategy - Offers Safe, Effective Alternative to Antiarrhythmic Drug Therapy for the Prevention of Atrial Arrythmia ...
Illustration of the Medtronic Arctic Front Advance Cryoballoon placed in the Left Superior Inferior Pulmonary Vein Medtronic ($MDT) announced concurrent FDA and CE ...
Medtronic plc MDT recently announced the receipt of the FDA’s expanded approval for Freezor and Freezor Xtra Cardiac Cryoablation. This approval is likely to bolster Medtronic’s cardiac Ablation ...
- Offers Safe, Effective Alternative to Antiarrhythmic Drug Therapy for the Prevention of Atrial Arrythmia Recurrence DUBLIN, June 21, 2021 /CNW/ -- Medtronic plc (NYSE: MDT), the global leader in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback